$1.67
0.010.60%
At Close: -
$1.67
00.00%
After Hours: 7:58 PM EDT
15 minutes delayed
Lexicon Pharmaceuticals
LXRXNASDAQ
Latest news for Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock
Lexicon Pharmaceuticals Stock (NASDAQ: LXRX)
Categories: All
Monday, June 24, 2024
Friday, June 21, 2024
Thursday, June 20, 2024
Tuesday, June 18, 2024
Monday, June 17, 2024
Friday, June 14, 2024
Friday, May 03, 2024
Thursday, May 02, 2024
Tuesday, April 30, 2024
Monday, April 29, 2024
Tuesday, April 23, 2024
Monday, April 22, 2024
Thursday, April 11, 2024
Wednesday, March 27, 2024
Monday, March 25, 2024
Tuesday, March 12, 2024
- Lexicon Pharmaceuticals, Inc. Announces New Post Hoc Analysis Of inTandem3 Study Demonstrates Improvements In Glycemic Control With Sotagliflozin Treatment In Patients With Type 1 Diabetes And Chronic Kidney Disease
- ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Monday, March 11, 2024
- Dow Turns Higher; GDS Holdings Shares Climb
- Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- Crude Oil Edges Higher; Lexicon Pharmaceuticals Shares Jump
- Lexicon Pharmaceuticals: Q4 Earnings Insights
- Lexicon shares are trading higher after the c...
- Lexicon Pharmaceuticals Q4 EPS $(0.20) Beats ...
- Lexicon Announces Oversubscribed $250M Privat...
- Lexicon Preparing To Resubmit Sotagliflozin N...